| Financial Year |
March 31 2023 |
| Monetary Funds |
474,492,456.58 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
95,430,775.92 |
| Accounts Receivable |
799,421,123.93 |
| Advances to Suppliers |
68,879,707.70 |
| Other Receivables |
166,537,652.48 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
265,380,226.47 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
75,230,149.76 |
| Total Current Assets |
2,071,882,900.29 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
194,780,229.48 |
| Investment Properties |
-- |
| Fixed Assetes |
395,499,938.72 |
| Under-construction Projects |
27,326,101.51 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
34,012,478.67 |
| R&D expenses |
-- |
| Goodwill |
558,815,700.28 |
| Long-Term Deferred and Prepaid Expenses |
4,098,012.06 |
| Deferred Income Tax Assets |
51,961,341.77 |
| Other Non-Current Assets |
84,695,371.14 |
| Sub-Total of Non-Current Assets |
1,450,752,954.39 |
| Total Assets |
3,522,635,854.68 |
| Short-Term Loans |
265,479,690.88 |
| Trading Financial liabilities |
-- |
| Notes Payable |
105,854,591.49 |
| Accounts Payable |
206,845,229.56 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
4,847,906.86 |
| Taxes Payable |
6,655,083.99 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
24,435,466.85 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,900,000.00 |
| Other Current Liabilities |
3,772,350.32 |
| Sub-Total of Current Liabilities |
646,513,246.75 |
| Long-term Loans |
136,481,679.20 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
207,430,037.49 |
| Total Liabilities |
853,943,284.24 |
| Paid-In Capital(Or Share Stock) |
828,623,861.00 |
| Capital Surplus |
2,425,828,810.36 |
| Surplus Reserve |
36,288,042.24 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-594,233,300.18 |
| Minority Stockholder's Interest |
9,969,433.00 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,658,723,137.44 |
| Owner's Equity（Stockholder's Equity） |
2,668,692,570.44 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,522,635,854.68 |
